Diseases

Explore disease pages that summarize symptoms, diagnostic context, and related care topics.

Featured: 100

Browse A-Z

Page 2 of 67

Diseases starting with U (6,629)

T365X6D

Underdosing of aminoglycosides, subsequent encounter

T43626A

Underdosing of amphetamines, initial encounter

T43626S

Underdosing of amphetamines, sequela

T43626D

Underdosing of amphetamines, subsequent encounter

T507X6A

Underdosing of analeptics and opioid receptor antagonists, initial encounter

T507X6S

Underdosing of analeptics and opioid receptor antagonists, sequela

T507X6D

Underdosing of analeptics and opioid receptor antagonists, subsequent encounter

T387X6A

Underdosing of androgens and anabolic congeners, initial encounter

T387X6S

Underdosing of androgens and anabolic congeners, sequela

T387X6D

Underdosing of androgens and anabolic congeners, subsequent encounter

T464X6A

Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter

T464X6S

Underdosing of angiotensin-converting-enzyme inhibitors, sequela

T464X6D

Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter

T38816A

Underdosing of anterior pituitary [adenohypophyseal] hormones, initial encounter

T38816S

Underdosing of anterior pituitary [adenohypophyseal] hormones, sequela

T38816D

Underdosing of anterior pituitary [adenohypophyseal] hormones, subsequent encounter

T374X6A

Underdosing of anthelminthics, initial encounter

T374X6S

Underdosing of anthelminthics, sequela

T374X6D

Underdosing of anthelminthics, subsequent encounter

T450X6A

Underdosing of antiallergic and antiemetic drugs, initial encounter

T450X6S

Underdosing of antiallergic and antiemetic drugs, sequela

T450X6D

Underdosing of antiallergic and antiemetic drugs, subsequent encounter

T486X6A

Underdosing of antiasthmatics, initial encounter

T486X6S

Underdosing of antiasthmatics, sequela

T486X6D

Underdosing of antiasthmatics, subsequent encounter

T440X6A

Underdosing of anticholinesterase agents, initial encounter

T440X6S

Underdosing of anticholinesterase agents, sequela

T440X6D

Underdosing of anticholinesterase agents, subsequent encounter

T457X6A

Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter

T457X6S

Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela

T457X6D

Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter

T45516A

Underdosing of anticoagulants, initial encounter

T45516S

Underdosing of anticoagulants, sequela

T45516D

Underdosing of anticoagulants, subsequent encounter

T476X6A

Underdosing of antidiarrheal drugs, initial encounter

T476X6S

Underdosing of antidiarrheal drugs, sequela

T476X6D

Underdosing of antidiarrheal drugs, subsequent encounter

T506X6A

Underdosing of antidotes and chelating agents, initial encounter

T506X6S

Underdosing of antidotes and chelating agents, sequela

T506X6D

Underdosing of antidotes and chelating agents, subsequent encounter

T367X6A

Underdosing of antifungal antibiotics, systemically used, initial encounter

T367X6S

Underdosing of antifungal antibiotics, systemically used, sequela

T367X6D

Underdosing of antifungal antibiotics, systemically used, subsequent encounter

T386X6A

Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter

T386X6S

Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela

T386X6D

Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter

T466X6A

Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter

T466X6S

Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela

T466X6D

Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter

T372X6A

Underdosing of antimalarials and drugs acting on other blood protozoa, initial encounter

T372X6S

Underdosing of antimalarials and drugs acting on other blood protozoa, sequela

T372X6D

Underdosing of antimalarials and drugs acting on other blood protozoa, subsequent encounter

T371X6A

Underdosing of antimycobacterial drugs, initial encounter

T371X6S

Underdosing of antimycobacterial drugs, sequela

T371X6D

Underdosing of antimycobacterial drugs, subsequent encounter

T451X6A

Underdosing of antineoplastic and immunosuppressive drugs, initial encounter

T451X6S

Underdosing of antineoplastic and immunosuppressive drugs, sequela

T451X6D

Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter

T428X6A

Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter

T428X6S

Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, sequela

T428X6D

Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter

T491X6A

Underdosing of antipruritics, initial encounter

T491X6S

Underdosing of antipruritics, sequela

T491X6D

Underdosing of antipruritics, subsequent encounter

T394X6A

Underdosing of antirheumatics, not elsewhere classified, initial encounter

T394X6S

Underdosing of antirheumatics, not elsewhere classified, sequela

T394X6D

Underdosing of antirheumatics, not elsewhere classified, subsequent encounter

T45526A

Underdosing of antithrombotic drugs, initial encounter

T45526S

Underdosing of antithrombotic drugs, sequela

T45526D

Underdosing of antithrombotic drugs, subsequent encounter

T382X6A

Underdosing of antithyroid drugs, initial encounter

T382X6S

Underdosing of antithyroid drugs, sequela

T382X6D

Underdosing of antithyroid drugs, subsequent encounter

T483X6A

Underdosing of antitussives, initial encounter

T483X6S

Underdosing of antitussives, sequela

T483X6D

Underdosing of antitussives, subsequent encounter

T468X6A

Underdosing of antivaricose drugs, including sclerosing agents, initial encounter

T468X6S

Underdosing of antivaricose drugs, including sclerosing agents, sequela

T468X6D

Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter

T375X6A

Underdosing of antiviral drugs, initial encounter

T375X6S

Underdosing of antiviral drugs, sequela

T375X6D

Underdosing of antiviral drugs, subsequent encounter

T505X6A

Underdosing of appetite depressants, initial encounter

T505X6S

Underdosing of appetite depressants, sequela

T505X6D

Underdosing of appetite depressants, subsequent encounter

T39016A

Underdosing of aspirin, initial encounter

T39016S

Underdosing of aspirin, sequela

T39016D

Underdosing of aspirin, subsequent encounter

T423X6A

Underdosing of barbiturates, initial encounter

T423X6S

Underdosing of barbiturates, sequela

T423X6D

Underdosing of barbiturates, subsequent encounter

T424X6A

Underdosing of benzodiazepines, initial encounter

T424X6S

Underdosing of benzodiazepines, sequela

T424X6D

Underdosing of benzodiazepines, subsequent encounter

T447X6A

Underdosing of beta-adrenoreceptor antagonists, initial encounter

T447X6S

Underdosing of beta-adrenoreceptor antagonists, sequela

T447X6D

Underdosing of beta-adrenoreceptor antagonists, subsequent encounter

T434X6A

Underdosing of butyrophenone and thiothixene neuroleptics, initial encounter

T434X6S

Underdosing of butyrophenone and thiothixene neuroleptics, sequela

T434X6D

Underdosing of butyrophenone and thiothixene neuroleptics, subsequent encounter